Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease
Authors:
- Ekkehard BayerdörfferEBEkkehard Bayerdörffer
- Marc-Andre BigardMBMarc-Andre Bigard
- Werner WeissWWWerner Weiss
- Fermín MearinFMFermín Mearin
- Luis RodrigoLuis Rodrigo
- Juan Enrique Dominguez MuñozJMJuan Enrique Dominguez Muñoz
- Hennie GrundlingHGHennie Grundling
- Tore PerssonTPTore Persson
- Lars-Erik SvedbergLSLars-Erik Svedberg
- Nanna KeelingNKNanna Keeling
- Stefan EklundSEStefan Eklund
Open Access
- 14 April 2016
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 16 (1) , 1-12
Abstract
Most patients with gastroesophageal reflux disease experience symptomatic relapse after stopping acid-suppressive medication. The aim of this study was to compare willingness to continue treatment with esomeprazole on-demand versus continuous maintenance therapy for symptom control in patients with non-erosive reflux disease (NERD) after 6 months. This multicenter, open-label, randomized, parallel-group study enrolled adults with NERD who were heartburn-free after 4 weeks’ treatment with esomeprazole 20 mg daily. Patients received esomeprazole 20 mg daily continuously or on-demand for 6 months. The primary variable was discontinuation due to unsatisfactory treatment. On-demand treatment was considered non-inferior if the upper limit of the one-sided 95 % confidence interval (CI) for the difference between treatments was <10 %. Of 877 patients enrolled, 598 were randomized to maintenance treatment (continuous: n = 297; on-demand: n = 301). Discontinuation due to unsatisfactory treatment was 6.3 % for on-demand and 9.8 % for continuous treatment (difference −3.5 % [90 % CI: −7.1 %, 0.2 %]). In total, 82.1 and 86.2 % of patients taking on-demand and continuous therapy, respectively, were satisfied with the treatment of heartburn and regurgitation symptoms, a secondary variable (P = NS). Mean study drug consumption was 0.41 and 0.91 tablets/day, respectively. Overall, 5 % of the on-demand group developed reflux esophagitis versus none in the continuous group (P < 0.0001). The Gastrointestinal Symptom Rating Scale Reflux dimension was also improved for continuous versus on-demand treatment. Esomeprazole was well tolerated. In terms of willingness to continue treatment, on-demand treatment with esomeprazole 20 mg was non-inferior to continuous maintenance treatment and reduced medication usage in patients with NERD who had achieved symptom control with initial esomeprazole treatment. ClinicalTrials.gov identifier (NCT number): NCT02670642 ; Date of registration: December 2015.Keywords
Funding Information
- AstraZeneca
This publication has 47 references indexed in Scilit:
- Prevention of Relapse of Healed Reflux Esophagitis is Related to the Duration of Intragastric pH>4Journal of Clinical Gastroenterology, 2010
- Nonerosive Reflux Disease (NERD) - An UpdateJournal of Neurogastroenterology and Motility, 2010
- Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study1Alimentary Pharmacology & Therapeutics, 2005
- A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux diseaseInternational Journal Of Clinical Practice, 2005
- Six-month management of patients following treatment for gastroesophageal reflux disease symptoms - a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical prInternational Journal Of Clinical Practice, 2005
- The interplay between Helicobacter pylori , gastro-oesophageal reflux disease, and intestinal metaplasiaGut, 2005
- Esomeprazole 20 mg on‐demand is more acceptable to patients than continuous lansoprazole 15 mg in the long‐term maintenance of endoscopy‐negative gastro‐oesophageal reflux patients: the COMMAND StudyAlimentary Pharmacology & Therapeutics, 2004
- Gastroesophageal reflux diseasePostgraduate Medicine, 2001
- Red Streaks in the Oesophagus in Patients with Reflux Disease: Is There a Histomorphological Correlate?Scandinavian Journal of Gastroenterology, 2001
- Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationGut, 1999